FDA Warns of Genital Infection Risk With Class of Diabetes Drugs

The FDA is warning that a rare genital infection may be linked to a class of diabetes drugs.

From March 2013 to May 2018, the agency said it received word of 12 cases of Fournier’s gangrene – a potentially life-threatening bacterial infection of tissue under the skin around the genitals – in people taking an SGLT2 (sodium-glucose cotransporter-2) inhibitor. One of the patients died and others required “multiple disfiguring surgeries” or experienced complications. The bacteria usually enters the body through a cut in the skin.

Common SGLT2 inhibitors are Farxiga (dapagliflozin), Invokana (canagliflozin), Jardiance (empagliflozin) and Steglatro (ertugliflozin).

The FDA pointed out that Fournier’s gangrene is extremely rare, occurring in 1.6 out of 100,000 males in the US annually. The agency said of the 12 cases it is aware of, 7 were in men and 5 were in women.

As a result of the reports, the FDA is requiring that a warning about the risk of Fournier’s gangrene be added to the prescribing information for all diabetes drugs like SGLT2 inhibitors.

DISCLAIMER: MedShadow provides information and resources related to medications, their effects, and potential side effects. However, it is important to note that we are not a substitute for professional medical advice, diagnosis, or treatment. The content on our site is intended for educational and informational purposes only. Individuals dealing with medical conditions or symptoms should seek guidance from a licensed healthcare professional, such as a physician or pharmacist, who can provide personalized medical advice tailored to their specific circumstances.

While we strive to ensure the accuracy and reliability of the information presented on MedShadow, we cannot guarantee its completeness or suitability for any particular individual's medical needs. Therefore, we strongly encourage users to consult with qualified healthcare professionals regarding any health-related concerns or decisions. By accessing and using MedShadow, you acknowledge and agree that the information provided on the site is not a substitute for professional medical advice and that you should always consult with a qualified healthcare provider for any medical concerns.

Was This Article Helpful?

Show Comments (0)
0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments